Special Offer! SAVE 15% with Promo Code: ASYMCHEM15

Hi E,

Next month the Fierce Biotech Summit will be returning to Boston on October 16-18th, with a who's who in Biotech coming together to share their experiences, insights and thoughts on the future of the industry.

Brought to you by the editors behind Fierce Biotech, this three-day event will cover the use of AI in drug development, unique dealmaking strategies, the latest innovations in oncology and much more with two tracks dedicated to Early Stage Development and Strategy and Dealmaking.

As a valued industry professional, we invite you to register today with promo code ASYMCHEM15 to SAVE 15%. We look forward to seeing you soon!

VCS AND INVESTORS IN ATTENDANCE INCLUDE:

• 6 Dimensions Capital
• Atlas Venture
• Blackstone Life Sciences
• Camford Capital
• Chestnut Partners
• Civilization Ventures
• CLI Ventures 
• Eos BioInnovation
• Flagship Pioneering
• Forty51 Ventures
• FoundersX Ventures
• Google Ventures
• Greater Zurich Area
• H Tree Capital
• H.C. Wainwright
  

• JDRF T1D Fund

• Johnson & Johnson Innovation – JJDC
  
• LifeArc Ventures
  
• Longliv Ventures
  
• LVF
  
• Michigan Biomedical Venture Fund
  
• Mizuho
  
• Noksha Capital
  
• Novo Nordisk Bio Innovation Hub
  
• Outcome Capital
  
• Polaris Partners
  
• Silverwood Partners
  
• Top Mark Capital
  
• Vibe Bio
  
• Vida Ventures
  
• And many more!

FEATURED SPEAKERS:

• Nadim Ahmed, President & CEO, Cullinan Oncology
• Samuel Blackman, M.D., Ph.D., Head of Research and Development & Co-Founder, Day One Biopharmaceuticals

• Marianne De Backer, M.Sc., Ph.D., MBA, CEO, Vir Biotechnology, Inc.

• Dr. Laura Gault, M.D., Ph.D., Chief Medical Officer, Sage Therapeutics
• William Grossman, M.D., Ph.D., SVP - Oncology Clinical Development, Therapeutic Area Head, Gilead Sciences
• Rachel King, CEO, Biotechnology Innovation Organization (BIO)
• Marian Nakada, Ph.D., Vice President, Venture Investments, Johnson & Johnson Innovation
• Joseph Panetta, President & CEO, Biocom California

• Peter Pitts, President, Center for Medicine in the Public Interest, and Former FDA Associate Commissioner

• Maha Radhakrishnan, M.D., Group SVP and Chief Medical Officer, Biogen

• Devyn Smith, CEO, Arbor Biotechnologies, and Chairman of ARM

• Ryan Spencer, CEO, Dynavax Technologies
• Uli Stilz, Vice President, Novo Nordisk Bio Innovation Hub
• Scott Weintraub, SVP, US Commercial Operations, Alexion
• Alice Zhang, CEO and Co-Founder, Verge Genomics

ESSENTIAL TOPICS YOU DON'T WANT TO MISS:

• The Next Blockbuster Indications

• The Inflation Reduction Act (IRA): The Dawn of a New Era - What Will it Mean for Innovation?

• Success in the Middle of a Downturn: Strategies for Weathering the Biotech Storm and Building Trust in the Market

• The Future of Oncology: Innovation and Advancements in the Biotech Industry

• Revolutionizing Drug Discovery and Development with AI: Maximizing Efficiency and Innovation in Biotech

• Fierce 15 Panel – Where are they now?

Book Your Stay Now at the Discounted Rate!

The Westin Boston Seaport District
425 Summer Street
Boston, MA 02210

Deadline: September 22, 2023

Thank You to Our 2023 Partners

Platinum

Gold

Silver

Sponsor

Exhibitors

Supporters

If you no longer wish to receive promotion on this event, simply unsubscribe.
Refer to our Privacy Policy.

Fierce Life Sciences is a division of Questex LLC.
685 3rd Ave 21st Floor New York, NY 10017

Contact Us
© 2023 Questex LLC. All Rights Reserved.
Reproduction in whole or in part is prohibited without written permission.